HeyJaredInvestor Meet Podcast - AI
An AI generated podcast feed from UK listed companies hosted on Investor Meet Company.
- Indexed episodes, last 90 days
- 23
- Latest publication
- Sep 15, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 10, 2026
Latest episodes
IP GROUP PLC - Half Year Results 2026 (opens the original)
Read excerpt
IP Group PLC’s H1 2026 investor update highlights continued progress across net asset value growth, cash realisations and portfolio development, reinforcing the strength of its long-term science and technology investment strategy. NAV per share increased 3.2% to 114 pence at 30 June 2026 and subsequently reached approximately 117 pence, while the Group generated £69 million in cash proceeds during the period and £154 million since the start of 2025, keeping it on track to achieve its £250 millio
STANDARD LIFE PLC - HY26 Results (opens the original)
Read excerpt
STANDARD LIFE PLC delivered a strong set of HY26 financial results, demonstrating continued momentum across its retirement savings and income strategy and remaining on track to achieve its 2026 targets. IFRS operating profit increased 25% to £563 million, while operating cash generation rose 6% to £745 million, supported by business growth, operating leverage and cumulative run-rate cost savings of £210 million. Pensions and savings operating profit grew 36% to £244 million, with average AUA inc
PROPERTY FRANCHISE GROUP PLC (THE) - Results for the six months ended 30 June 2026 (opens the original)
Read excerpt
PROPERTY FRANCHISE GROUP PLC (THE) delivered another record half-year performance for the six months ended 30 June 2026, with revenue rising 7% to £43.3 million and adjusted profit before tax increasing 7% to £15.5 million. Adjusted basic EPS grew 8% to 19.8p, while strong cash generation supported a 10% increase in the interim dividend to 7.7p and reduced net debt to £8.1 million. The Group’s resilient franchise model continues to benefit from its lettings-led recurring revenue base, with 149,0
ONDINE BIOMEDICAL INC. - Investor Presentation of Phase 3 Topline Results (opens the original)
Read excerpt
Ondine Biomedical Inc. presented positive topline results from its pivotal Phase 3 LANTERN study of nasal photodisinfection for the prevention of surgical site infections (SSIs). The study enrolled more than 5,000 patients across 18 hospitals in the US and Canada, including 14 HCA Healthcare hospitals, and achieved its primary efficacy endpoint with a 98.2% probability of benefit. Nasal photodisinfection alongside standard of care delivered a 40.5% lower risk of 30-day SSIs compared with standar
ITACONIX PLC - Interim Results for the year ended 30 June 2026 (opens the original)
Read excerpt
Itaconix PLC delivered a record first half of 2026, with revenue increasing 72% to $8.3 million and the Group achieving adjusted EBITDA break-even for the first time, marking a significant milestone in its growth strategy. Performance Ingredients revenue more than doubled to $6.7 million, driven by higher reorder volumes from existing customers and new customer wins, while gross profit increased 74% to $3.0 million and gross margins remained stable at 36%. EMEA was a standout growth market, with
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.